STAREE Trial Shows Statins Benefit Healthy Older Adults in Primary Prevention
Source Summary
A major randomized trial demonstrated that daily atorvastatin 40 mg showed clear benefit over placebo for primary prevention in healthy older adults. This marks the first time a large-scale trial has established a role for statin therapy in this population.
Why it matters
This trial result provides evidence supporting statin use for cardiovascular disease prevention in healthy older adults, a population for which primary prevention benefits were previously unclear.
